Abstract
Means and methods for monitoring the quality of the new Russian radiopharmaceutical preparation, 99mTc-HEDP, for radionuclide diagnosis of bone pathology were developed, along with reagents for its preparation.
Similar content being viewed by others
References
P. M. Saliman, Anal. Chem., 36, No. 1, 112–114 (1964).
K. P. Quinlan and M. A. DeSesa, Anal. Chem., 27, No. 10, 1626–1629 (1955).
S. A. Morosanova and O. G. Cherkasova, Zh. Anal. Khim, 34, No. 2, 309–313 (1979).
M. Kato-Azuma and M. Hazue, J. Label. Comp. Radiopharm., XIX, No. 11–12, 1542–1544 (1982).
V. Koltunov and T. Gomonova, Extended Synposes of Reports to the 3rd Russian-Japanese Seminar on Technetium, Dubna (2002), pp. 118–120.
E. i. Morosanova, N. M. Kuz'min, and Yu. A. Zolotov, Fresen. J. Anal. Chem., 537, No. 7, 853–859 (1997).
E. I. Morosanova, N. M. Kuz'min, A. A. Velikorodnyi, and E. A. Reznikov, Zh. Anal. Khim., 55, No. 4, 423–429 (2000).
E. i. Morosanova, A. A. Velikorodnyi, N. M. Kuz'min, and Yu. A. Zolotov, Russian Federation patent No. RF 2139243.
FSP (Manufacturer's Pharmacopeia Article) 42-02254528-03. Sodium pertechnetate solution, 99mTc, from a generator.
G. A. Petrova, V. M. Petriev, and V. G. Skvortsov, Vopr. Biol. Med. Farm. Khim., No. 2, 14–18 (2003).
Author information
Authors and Affiliations
Additional information
__________
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 42, No. 5, pp. 50–56, May, 2008.
Rights and permissions
About this article
Cite this article
Épshtein, N.B., Morosanova, E.I., Ya, Y. et al. Analytical monitoring of the quality of the radiopharmaceutical 99mTc-HEDP for radionuclide diagnosis of bone pathology. Pharm Chem J 42, 301–307 (2008). https://doi.org/10.1007/s11094-008-0113-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-008-0113-y